Literature DB >> 9404201

Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy.

S Krämer1, J Görich, H W Gottfried, P Riska, A J Aschoff, N Rilinger, H J Brambs, R Sokiranski.   

Abstract

The aim of this study was to evaluate CT imaging in the post-operative follow-up and in the detection of recurrence after radical prostatectomy in cases of prostatic carcinoma. In over 500 patients undergoing radical prostatectomy for prostatic carcinoma, 22 cases with local recurrence were found. CT examinations of the pelvis were retrospectively evaluated in these patients. Local recurrence was detected by PSA uptake and confirmed by transrectal ultrasound (TRUS) in combination with guided biopsy. In 22 cases of confirmed local recurrence, positive results on CT were found in eight patients (36%) and negative results in nine patients (41%). In the remaining five cases (23%), no distinction could be made between scar and local recurrence. All cases definitively classified as recurrent tumour disease showed a soft tissue mass of 2 cm or more. CT sensitivity in local recurrence of prostatic carcinoma after surgery is low. Even in a very careful follow-up, the understaging would be up to 41%. In comparison, PSA, TRUS and needle biopsy are the methods of choice and are superior to CT imaging. Based on these results, there would be no reason for including pelvic CT examinations in the follow-up of prostatic carcinoma after radical prostatectomy.

Entities:  

Mesh:

Year:  1997        PMID: 9404201     DOI: 10.1259/bjr.70.838.9404201

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  21 in total

Review 1.  Prostate cancer: a comprehensive review.

Authors:  S N Pentyala; J Lee; K Hsieh; W C Waltzer; A Trocchia; L Musacchia; M J Rebecchi; S A Khan
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

Review 2.  [PSA recurrence after primary curative therapy--local or systemic? When is a second curative therapy still possible?].

Authors:  M P Wirth; F M Engelhardt
Journal:  Urologe A       Date:  2005-09       Impact factor: 0.639

3.  Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT.

Authors:  David M Schuster; Bital Savir-Baruch; Peter T Nieh; Viraj A Master; Raghuveer K Halkar; Peter J Rossi; Melinda M Lewis; Jonathon A Nye; Weiping Yu; F DuBois Bowman; Mark M Goodman
Journal:  Radiology       Date:  2011-04-14       Impact factor: 11.105

4.  The value of multimodality imaging in the investigation of a PSA recurrence after radical prostatectomy in the Irish hospital setting.

Authors:  L C McLoughlin; S Inder; D Moran; C O'Rourke; R P Manecksha; T H Lynch
Journal:  Ir J Med Sci       Date:  2017-06-13       Impact factor: 1.568

5.  Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging.

Authors:  Stefano Cirillo; Massimo Petracchini; Lorenza Scotti; Teresa Gallo; Annalisa Macera; Maria Cristina Bona; Cinzia Ortega; Pietro Gabriele; Daniele Regge
Journal:  Eur Radiol       Date:  2008-09-30       Impact factor: 5.315

6.  Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature.

Authors:  Chung Yao Yu; Bhushan Desai; Lingyun Ji; Susan Groshen; Hossein Jadvar
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-09-06

Review 7.  Imaging assessment of local recurrence of prostate cancer after radical prostatectomy.

Authors:  Michael J Magnetta; David Casalino; Matthew T Heller
Journal:  Abdom Radiol (NY)       Date:  2020-12

8.  [Imaging diagnostics of advanced prostate cancer].

Authors:  A Kretschmer; M Seitz; A Graser; C G Stief; D Tilki
Journal:  Urologe A       Date:  2013-04       Impact factor: 0.639

9.  Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide?

Authors:  Hebert Alberto Vargas; Alexandre G Martin-Malburet; Toshikazu Takeda; Renato B Corradi; James Eastham; Andreas Wibmer; Evis Sala; Michael J Zelefsky; Wolfgang A Weber; Hedvig Hricak
Journal:  Urol Oncol       Date:  2016-06-23       Impact factor: 3.498

10.  The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

Authors:  B J Krause; M Souvatzoglou; M Tuncel; K Herrmann; A K Buck; C Praus; T Schuster; H Geinitz; U Treiber; M Schwaiger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-22       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.